Early Economic and Patient-Centered Outcomes Before Spine Metastases Radiation Therapy From an Ongoing Phase II Randomized Controlled Trial

OBJECTIVES: The incidence of metastatic spine cancer is increasing, with up to 40% of patients with metastatic disease developing spine involvement. Radiotherapy options involve conventional external beam radiation therapy (EBRT) and stereotactic body radiotherapy (SBRT). However, comparative economic impact and patient-reported financial burden remain poorly defined. This study evaluates early economic and patient-centered outcomes using prospective data from an ongoing randomized trial. METHODS: This analysis is embedded within the multicenter phase II/III Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN) trial (ClinicalTrials.gov: NCT05617716). Patients with MRI-confirmed spinal metastases and histologically confirmed primary malignancy are randomized to SBRT (24 Gy/2 fractions or 19 Gy/1 fraction) or conventional EBRT (8 Gy/1 fraction). Patient-reported financial toxicity (FT) and health-related quality of life are assessed using the COST-FACIT and EQ-5D-5L instruments. RESULTS: Of patients with baseline data, 60% reported grade 1 to 2 financial toxicity, while 40% reported none. All patients with individual FT also endorsed familial financial strain, with a strong positive correlation between individual and familial FT (r=0.71). Baseline EQ-5D-5L scores demonstrated moderate impairment in mobility (3.3), self-care (2.6), and usual activities (3.3), severe pain (3.9), and mild anxiety/depression (2.2). CONCLUSIONS: Preliminary findings suggest that financial toxicity is present in a majority of SPORTSMEN patients before treatment and is strongly associated with familial financial strain, highlighting the importance of early financial screening and intervention at the time of diagnosis. Baseline EQ-5D-5L data further demonstrate substantial functional impairment and pain burden, underscoring the need for early supportive and multidisciplinary interventions.

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Oncology
Published
2026-06-16
DOI
https://doi.org/10.1097/coc.0000000000001346
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Economic and Patient-Centered Outcomes Before Spine Metastases Radiation Therapy From an Ongoing Phase II Randomized Controlled Trial

Momina Anwar, Shearwood McClelland III, Lisa Perry, Nancy Cleaver et al.
American Journal of Clinical Oncology
Management of metastatic bone disease
article

Early Economic and Patient-Centered Outcomes Before Spine Metastases Radiation Therapy From an Ongoing Phase II Randomized Controlled Trial

Momina Anwar, Shearwood McClelland III, Lisa Perry, Nancy Cleaver, Ena C. Oboh
article en

Abstract

OBJECTIVES: The incidence of metastatic spine cancer is increasing, with up to 40% of patients with metastatic disease developing spine involvement. Radiotherapy options involve conventional external beam radiation therapy (EBRT) and stereotactic body radiotherapy (SBRT). However, comparative economic impact and patient-reported financial burden remain poorly defined. This study evaluates early economic and patient-centered outcomes using prospective data from an ongoing randomized trial. METHODS: This analysis is embedded within the multicenter phase II/III Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN) trial (ClinicalTrials.gov: NCT05617716). Patients with MRI-confirmed spinal metastases and histologically confirmed primary malignancy are randomized to SBRT (24 Gy/2 fractions or 19 Gy/1 fraction) or conventional EBRT (8 Gy/1 fraction). Patient-reported financial toxicity (FT) and health-related quality of life are assessed using the COST-FACIT and EQ-5D-5L instruments. RESULTS: Of patients with baseline data, 60% reported grade 1 to 2 financial toxicity, while 40% reported none. All patients with individual FT also endorsed familial financial strain, with a strong positive correlation between individual and familial FT (r=0.71). Baseline EQ-5D-5L scores demonstrated moderate impairment in mobility (3.3), self-care (2.6), and usual activities (3.3), severe pain (3.9), and mild anxiety/depression (2.2). CONCLUSIONS: Preliminary findings suggest that financial toxicity is present in a majority of SPORTSMEN patients before treatment and is strongly associated with familial financial strain, highlighting the importance of early financial screening and intervention at the time of diagnosis. Baseline EQ-5D-5L data further demonstrate substantial functional impairment and pain burden, underscoring the need for early supportive and multidisciplinary interventions.

American Journal of Clinical Oncology
George Washington University (US), Neurological Surgery (US), University of Oklahoma (US)
Partnerships for the goals
Openalex Percentile: Top 6%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.